Appropriate Antimicrobial Therapy in Critically Ill Patients

作者: Fekade B. Sime , Jason A. Roberts

DOI: 10.1007/978-3-319-59704-1_21

关键词:

摘要: Appropriate antibiotic therapy in the critically ill requires more specialised considerations than just selecting most suitable and adhering to traditional dosing guidelines. Unfortunately, of guideline recommendations are based on research that either underrepresent or exclude patients. The pathophysiology critical illness, as case intraabdominal sepsis, has many unique features unseen noncritically These include inconsistent changes important physiological phenomena govern drug disposition. It follows disposition several antimicrobials is markedly different variable relative described by development clinical trials often conducted healthy volunteers Drug determines how much a dose administer; thus altered simply means required for patients ensure optimal effects likely be different. Indeed studies have illustrated standard doses such beta-lactam antibiotics, vancomycin, aminoglycosides, fluoroquinolones fluconazole largely inadequate due high variability Therefore, regimens should tailored requirements individual This chapter presents discussion current understandings special appropriate with sepsis.

参考文章(163)
Galandiuk S, Young S, Montgomery W, Polk Hc, Lamos J, Antibiotic penetration of experimental intra-abdominal abscesses. American Surgeon. ,vol. 61, pp. 521- 525 ,(1995)
Mohd Hafiz Abdul-Aziz, Christine Staatz, Carl Kirkpatrick, Jeffrey Lipman, Jason Roberts, Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiologica. ,vol. 78, pp. 94- 104 ,(2012)
Honnas Cm, Brumbaugh Gw, Chaffin Mk, Nguyen J, Kemper Dl, Easter Jl, Hague Ba, Effects of postoperative peritoneal lavage on pharmacokinetics of gentamicin in horses after celiotomy. American Journal of Veterinary Research. ,vol. 58, pp. 1166- 1170 ,(1997)
Zachary C. Dietch, Puja M. Shah, Robert G. Sawyer, Advances in Intra-abdominal Sepsis: What Is New? Current Infectious Disease Reports. ,vol. 17, pp. 40- ,(2015) , 10.1007/S11908-015-0497-2
A Suarez de la Rica, E Maseda, V Anillo, C Hernandez-Gancedo, A Lopez-Tofiño, M Villagran, F Gilsanz, Risk factors for acute kidney injury in patients with complicated intra-abdominal infection Critical Care. ,vol. 19, pp. 284- ,(2015) , 10.1186/CC14364
P Depuydt, E Hoste, J Decruyenaere, M Carlier, S C Wallis, J Lipman, J De Waele, J A Roberts, Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysis. Minerva Anestesiologica. ,vol. 80, pp. 1302- 1309 ,(2014)
Michiel Haeseker, Leo Stolk, Fred Nieman, Christian Hoebe, Cees Neef, Cathrien Bruggeman, Annelies Verbon, The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens British Journal of Clinical Pharmacology. ,vol. 75, pp. 180- 185 ,(2013) , 10.1111/J.1365-2125.2012.04337.X
J Y Cheong, M Makmor-Bakry, C L Lau, R Abdul Rahman, The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients South African Medical Journal. ,vol. 102, pp. 616- 619 ,(2012) , 10.7196/SAMJ.5343
J. Gonçalves-Pereira, A. Martins, P. Póvoa, Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. Clinical Microbiology and Infection. ,vol. 16, pp. 1258- 1263 ,(2010) , 10.1111/J.1469-0691.2009.03074.X
Zhengwen Xiao, Crystal Wilson, Helen Lee Robertson, Derek J. Roberts, Chad G. Ball, Craig N. Jenne, Andrew W. Kirkpatrick, Inflammatory mediators in intra-abdominal sepsis or injury – a scoping review Critical Care. ,vol. 19, pp. 373- 373 ,(2015) , 10.1186/S13054-015-1093-4